Cynthia A Vistica

Title: Cynthia A Vistica: Innovator in Monoclonal Antibodies

Introduction

Cynthia A Vistica is a prominent inventor based in Dublin, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies. With a total of four patents to her name, her work has the potential to impact various medical treatments.

Latest Patents

Cynthia's latest patents focus on human monoclonal antibodies to fucosyl-GM1 and methods for using these antibodies. The patents disclose isolated monoclonal antibodies that specifically bind to fucosyl-GM1 with high affinity. They also include nucleic acid molecules encoding these antibodies, expression vectors, and host cells for their expression. Additionally, the patents provide methods for detecting fucosyl-GM1 and treating diseases, including cancer, using anti-fucosyl-GM1 antibodies.

Career Highlights

Throughout her career, Cynthia has worked with notable companies such as E.R. Squibb & Sons, LLC and Medarex Inc. Her experience in these organizations has contributed to her expertise in the field of antibody development and biotechnology.

Collaborations

Cynthia has collaborated with esteemed colleagues, including Eric H Holmes and Peter Brams. These partnerships have likely enhanced her research and innovation efforts in the biotechnology sector.

Conclusion

Cynthia A Vistica is a trailblazer in the field of monoclonal antibodies, with a focus on innovative treatments for diseases. Her contributions through patents and collaborations highlight her significant role in advancing medical science.